Scarica l'app Stockscreener
392.22
1.39%
-5.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUM Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$397.76
Aprire:
$398.66
Volume 24 ore:
1.77M
Relative Volume:
1.06
Capitalizzazione di mercato:
$47.09B
Reddito:
$137.20B
Utile/perdita netta:
$1.15B
Rapporto P/E:
41.98
EPS:
9.3439
Flusso di cassa netto:
$1.27B
1 W Prestazione:
-1.14%
1M Prestazione:
+7.62%
6M Prestazione:
+41.67%
1 anno Prestazione:
+68.93%
Intervallo 1D:
$390.46
$398.66
Intervallo di 1 settimana:
$388.10
$405.05
Portata 52W:
$163.11
$415.00
Humana Inc Stock (HUM) Company Profile
Nome
Humana Inc
Settore
Industria
Telefono
(502) 580-1000
Indirizzo
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
392.22 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
424.62 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.15 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
416.23 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
293.46 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-14 | Iniziato | Goldman | Sell |
| 2025-09-22 | Iniziato | Evercore ISI | In-line |
| 2025-05-01 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-10-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-03-22 | Iniziato | Raymond James | Mkt Perform |
| 2024-03-13 | Downgrade | Argus | Buy → Hold |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-01-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Aggiornamento | Argus | Hold → Buy |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Downgrade | Argus | Buy → Hold |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-10-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Iniziato | Bernstein | Mkt Perform |
| 2022-04-13 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-04 | Reiterato | Barclays | Overweight |
| 2021-11-04 | Reiterato | Credit Suisse | Outperform |
| 2021-11-04 | Reiterato | Morgan Stanley | Overweight |
| 2021-11-04 | Reiterato | Oppenheimer | Outperform |
| 2021-11-04 | Reiterato | RBC Capital Mkts | Outperform |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-09-09 | Ripresa | Barclays | Overweight |
| 2021-07-09 | Iniziato | Seaport Global Securities | Neutral |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-01-04 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Iniziato | Bernstein | Mkt Perform |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-16 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-06-05 | Iniziato | Goldman | Buy |
| 2020-01-03 | Reiterato | JP Morgan | Overweight |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Iniziato | UBS | Neutral |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Reiterato | BofA/Merrill | Buy |
| 2018-09-13 | Iniziato | Barclays | Overweight |
| 2018-07-12 | Ripresa | Morgan Stanley | Overweight |
| 2018-07-06 | Reiterato | Piper Jaffray | Overweight |
| 2018-06-01 | Ripresa | Citigroup | Buy |
| 2018-02-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Reiterato | Leerink Partners | Outperform |
| 2018-01-12 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Humana Inc Borsa (HUM) Ultime notizie
ARGA Investment Management LP Purchases 7,013 Shares of Humana Inc. $HUM - MarketBeat
Is ELV's Capital Allocation Strategy Creating Long-Term Value? - TradingView
Can UNH's Lifestyle Spending Account Redefine Employee Benefits? - TradingView
Swedbank AB Has $15.21 Million Stock Position in Humana Inc. $HUM - MarketBeat
Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Humana (HUM) Stock Looks Fully Priced On Illinois Medicaid Win - Sahm
UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings? - TradingView
Humana Inc Profile: Recipients - OpenSecrets
Humana Inc outlook and business model as health insurance demand stays robust - AD HOC NEWS
Humana Earnings Preview: What to Expect - Yahoo Finance
Cantor Fitzgerald raises Humana stock price target on Medicaid data - Investing.com
Cantor Fitzgerald reiterates Neutral on Humana stock at $264 - Investing.com
Cantor Fitzgerald reiterates Neutral on Humana stock at $264 By Investing.com - Investing.com Canada
Humana Inc. (HUM) Stock Analysis: Navigating Market Dynamics with a 23.50% Revenue Growth in Healthcare Plans - DirectorsTalk Interviews
UNH, Humana, CVS Soar, and Wall Street Analysts Take NoteUnitedHealth Group (NYSE:UNH), Humana (NYSE:H - Benzinga
Law firm probes Humana officers for possible br... - Pluang
HUMHumana Inc Latest SEC Filings - Finviz
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Shareholders to Connect - ACCESS Newswire
Humana (HUM) director Hilzinger granted 233 RSUs, holds 19,448 shares - Stock Titan
Humana Inc (HUM) Stock Down 3.1% but Still Overvalued -- GF Scor - GuruFocus
Humana Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Is Humana's (HUM) Loneliness Grants Strategy Hinting at a Deeper Medicare Advantage Narrative Shift? - simplywall.st
Humana Foundation awards $12M to combat loneliness among seniors - The Business Journals
Humana Inc (HUM) Shares Surge 3.1% -- What GF Score of 87 Tells Investors - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana, Centene lead healthcare rally in Q2 over Medicare Advantage optimism - Seeking Alpha
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants - Humana
How CenterWell Is Driving Humana's Growth Beyond Insurance - Zacks Investment Research
UnitedHealth, Humana and CVS Denied Post-Hospital Care At Some Of The Highest Rates - Neurology Advisor
2026-06-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Shareholders to Learn More About the Investigation | NYSE:HUM | Press Release - Stockhouse
Humana Inc. Actuals & Estimates (NYSE:HUM) - TradingView
Humana Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Humana Inc. Actuals & Estimates (MUN:HUM) - TradingView
Humana stock hits 52-week high at 381.2 USD By Investing.com - Investing.com Nigeria
Humana stock hits 52-week high at 381.2 USD - Investing.com
Humana Inc. Actuals & Estimates (BMV:HUM) - TradingView
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. Actuals & Estimates (XETR:HUM) - TradingView
Humana Inc. Actuals & Estimates (BIVA:HUM) - TradingView
Humana Inc.: - marketscreener.com
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $362.88 v - GuruFocus
Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM) - Yahoo Finance
Price to sales forward of Humana Inc. – NYSE:HUM - TradingView
Humana Inc. $HUM Shares Sold by Leeward Investments LLC MA - MarketBeat
Price to earnings forward of Humana Inc. – NYSE:HUM - TradingView
Did Humana’s (HUM) Illinois Medicaid Win and MA Uncertainty Just Rebalance Its Risk Profile? - simplywall.st
UnitedHealth, Humana and CVS denied post-hospital care at some of the highest rates - Medical Xpress
Can Humana's Margin Recovery Drive Long-Term Earnings Growth? - The Globe and Mail
UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates - U.S. News & World Report
HUM News | HUMANA INC (NYSE:HUM) - ChartMill
Humana Inc Azioni (HUM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):